134 related articles for article (PubMed ID: 21894172)
1. Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosis.
Flies A; Ahmadi T; Parks AJ; Prokaeva T; Weng L; Rolfe SS; Seldin DC; Sherr DH
Immunol Cell Biol; 2012 May; 90(5):528-39. PubMed ID: 21894172
[TBL] [Abstract][Full Text] [Related]
2. Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues.
Harig S; Witzens M; Krackhardt AM; Trojan A; Barrett P; Broderick R; Zauls AJ; Gribben JG
Blood; 2001 Nov; 98(10):2999-3005. PubMed ID: 11698283
[TBL] [Abstract][Full Text] [Related]
3. Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
Lotz C; Mutallib SA; Oehlrich N; Liewer U; Ferreira EA; Moos M; Hundemer M; Schneider S; Strand S; Huber C; Goldschmidt H; Theobald M
J Immunol; 2005 Jul; 175(2):1301-9. PubMed ID: 16002735
[TBL] [Abstract][Full Text] [Related]
4. Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1.
Maecker B; von Bergwelt-Baildon MS; Sherr DH; Nadler LM; Schultze JL
Int J Cancer; 2005 Jun; 115(2):333-6. PubMed ID: 15688394
[TBL] [Abstract][Full Text] [Related]
5. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo.
Tu SH; Huang HI; Lin SI; Liu HY; Sher YP; Chiang SK; Chong P; Roffler S; Tseng GC; Chen HW; Liu SJ
J Immunother; 2012 Apr; 35(3):235-44. PubMed ID: 22421941
[TBL] [Abstract][Full Text] [Related]
6. Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein.
Street MD; Doan T; Herd KA; Tindle RW
Immunology; 2002 Aug; 106(4):526-36. PubMed ID: 12153516
[TBL] [Abstract][Full Text] [Related]
7. The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells.
Maecker B; Sherr DH; Vonderheide RH; von Bergwelt-Baildon MS; Hirano N; Anderson KS; Xia Z; Butler MO; Wucherpfennig KW; O'Hara C; Cole G; Kwak SS; Ramstedt U; Tomlinson AJ; Chicz RM; Nadler LM; Schultze JL
Blood; 2003 Nov; 102(9):3287-94. PubMed ID: 12869499
[TBL] [Abstract][Full Text] [Related]
8. Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.
Bae J; Smith R; Daley J; Mimura N; Tai YT; Anderson KC; Munshi NC
Clin Cancer Res; 2012 Sep; 18(17):4850-60. PubMed ID: 22753586
[TBL] [Abstract][Full Text] [Related]
9. Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
Bae J; Tai YT; Anderson KC; Munshi NC
Br J Haematol; 2011 Nov; 155(3):349-61. PubMed ID: 21902685
[TBL] [Abstract][Full Text] [Related]
10. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
Kim S; Li L; McMurtrey CP; Hildebrand WH; Weidanz JA; Gillanders WE; Diamond MS; Hansen TH
J Immunol; 2010 Apr; 184(8):4423-30. PubMed ID: 20212098
[TBL] [Abstract][Full Text] [Related]
11. Analysis of plasma cell clonality in localized AL amyloidosis.
Setoguchi M; Hoshii Y; Kawano H; Ishihara T
Amyloid; 2000 Mar; 7(1):41-5. PubMed ID: 10842704
[TBL] [Abstract][Full Text] [Related]
12. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
[TBL] [Abstract][Full Text] [Related]
13. Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicity.
Petersen TR; Buus S; Brunak S; Nissen MH; Sherman LA; Claesson MH
Scand J Immunol; 2001 Apr; 53(4):357-64. PubMed ID: 11285115
[TBL] [Abstract][Full Text] [Related]
14. Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma.
Kang YJ; Zeng W; Song W; Reinhold B; Choi J; Brusic V; Yamashita T; Munshi A; Li C; Minvielle S; Anderson KC; Munshi N; Reinherz EL; Sasada T
Br J Haematol; 2013 Nov; 163(3):343-51. PubMed ID: 24032635
[TBL] [Abstract][Full Text] [Related]
15. Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.
Hernandez J; Garcia-Pons F; Lone YC; Firat H; Schmidt JD; Langlade-Demoyen P; Zanetti M
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12275-80. PubMed ID: 12218171
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.
Ward JE; Ren R; Toraldo G; Soohoo P; Guan J; O'Hara C; Jasuja R; Trinkaus-Randall V; Liao R; Connors LH; Seldin DC
Blood; 2011 Dec; 118(25):6610-7. PubMed ID: 21998211
[TBL] [Abstract][Full Text] [Related]
17.
Schmidt J; Guillaume P; Dojcinovic D; Karbach J; Coukos G; Luescher I
J Biol Chem; 2017 Jul; 292(28):11840-11849. PubMed ID: 28536262
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide.
Gross DA; Leborgne C; Chappert P; Masurier C; Leboeuf M; Monteilhet V; Boutin S; Lemonnier FA; Davoust J; Kichler A
Sci Rep; 2019 Mar; 9(1):3937. PubMed ID: 30850685
[TBL] [Abstract][Full Text] [Related]
20. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
